Search

Author/Creator Aspeslagh, Sandrine

1. 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial. (20th October 2022)

Authors:
De Jaeghere, Emiel A; Tuyaerts, Sandra; van Nuffel, An MT; Belmans, Ann; Bogaerts, Kris; Baiden-Amissah, Regina; Vuylsteke, Peter; Henry, Stéphanie; Trinh, Xuan Bich; van Dam, Peter A; Aspeslagh, Sandrine; de Caluwé, Alex; Naert, Eline; Lambrechts, Diether; Hendrix, An; de Wever, Olivier; van de ...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors). (October 2017)

Authors:
Sun, Roger; Champiat, Stéphane; Dercle, Laurent; Aspeslagh, Sandrine; Castanon, Eduardo; Limkin, Elaine Johanna; Baldini, Capucine; Postel-Vinay, Sophie; Hollebecque, Antoine; Massard, Christophe; Ammari, Samy; Deutsch, Eric; Soria, Jean-Charles; Marabelle, Aurélien; Ferté, Charles
Journal:
European journal of cancer
Issue:
Volume 84(2017)
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting. Issue 4 (August 2021)

Authors:
Lauwyck, Justine; Beckwée, Aline; Santens, Arno; Schwarze, Julia Katharina; Awada, Gil; Vandersleyen, Valérie; Aspeslagh, Sandrine; Neyns, Bart
Journal:
Melanoma research
Issue:
Volume 31:Issue 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Case Report - Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor. Issue 2 (February 2016)

Authors:
Benderra, Marc‐Antoine; Aspeslagh, Sandrine; Postel‐Vinay, Sophie; Bigot, Ludovic; De Baere, Thierry; Loriot, Yohann; Lacroix, Ludovic; Massard, Christophe; Vassal, Gilles; André, Fabrice; Soria, Jean‐Charles
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 2(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)

Authors:
Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Ra...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗